BFRA - Biofrontera AG

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5315.64M
Enterprise Value 3321.62M
Trailing P/E N/A
Forward P/E 1-22.62
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)21.02
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin -71.42%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-29.53%
Return on Equity (ttm)-154.33%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)139.80%
Gross Profit (ttm)10.31M
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.76
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)103.06
Current Ratio (mrq)6.28
Book Value Per Share (mrq)0.68

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 0.52
52-Week Change 33.08%
S&P500 52-Week Change 38.63%
52 Week High 316.06
52 Week Low 311.04
50-Day Moving Average 312.97
200-Day Moving Average 312.81

Share Statistics

Avg Vol (3 month) 31.59k
Avg Vol (10 day) 31.74k
Shares Outstanding 544.57M
Float 12.22M
% Held by Insiders 10.04%
% Held by Institutions 12.04%
Shares Short (Mar 29, 2019) 4343
Short Ratio (Mar 29, 2019) 40.32
Short % of Float (Mar 29, 2019) 4N/A
Short % of Shares Outstanding (Mar 29, 2019) 40.00%
Shares Short (prior month Feb 28, 2019) 4102

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A